Macular Degeneration Flashcards
1
Q
Risk factors for AMD
A
age, family history, cataract surgery, smoking, native American ancestry, HTN, diabetes, lack of regular exercise (<3x a week)
2
Q
What is AREDS1
A
No AMD
- Normal signs of again
- No - few small drusen <63um.
- 15% conversion to intermediate AMD within 10 years
3
Q
What is AREDS2
A
Early AMD
- Combination of:
o Multiple small drusen
o Few intermediate drusen (63-124um)
o Mild RPE abnormalities - 15% conversion to intermediate AMD within 10 years
4
Q
What is AREDS3
A
- Many intermediate drusen
- ≥1 large drusen (>125 um)
- Geographic atrophy
5
Q
What is AREDS4
A
- Geographic atrophy (involving foveal centre) - requires FA to exclude other inherited retinal disease.
- Neovascularisation maculopathy: CNV, hard exudates, subretinal and sub RPE fibrovascular proliferation
6
Q
AREDS1 Management
A
Management: Observation only.
7
Q
AREDS2 Management
A
- Observation only
- Regular exercise (≥3x/week)
- Cease smoking.
8
Q
AREDS3 Management
A
- Dietary Advice
a. Dark green leafy vegetable daily
b. Oily fish 2 – 3 x a week
c. Low GI carbohydrates
d. Handful of nuts weekly
e. Limit consumption of saturated fats/oils - Regular exercise (≥3x/week)
- Cease smoking.
- Daily supplements:
a. 500mg vitamin C
b. 400IU vitamin E
c. 15 mg Beta – carotene OR 10mg Lutein and 2mg zeaxanthin and 25mg zinc oxide
d. 80mg zinc oxide (if usually beta – carotene)
e. Copper (2mg as cupric oxide)
9
Q
AREDS4 Management
A
- Referral to ophthalmology for Anti – VEGF (ranibizumab or Aflibercept)
a. May consider in combination with iRay radiation
b. Risk of ischemic cardiac event (stroke), elevated IOP - Potential Treatment
a. Pegcetocoplan PM or PEOM injections
b. Aracincaptad Pegol
c. Gene therapy – factor B antisense with RNA target
10
Q
Calculate rate of progression to late AMD
A
Right eye
Large Drusen = 1
Pigment Change = 1
Left eye
Large Drusen = 1
Pigment Change = 1
0 = 0%
1 = 3%
2 = 9%
3 = 27%
4 = 43%